Literature DB >> 9267821

Liver biopsy in neonatal cholestasis: a review on statistical grounds.

M C Zerbini1, S D Gallucci, R Maezono, C M Ueno, G Porta, J G Maksoud, L C Gayotto.   

Abstract

The aim of this study was to improve the accuracy of the histopathologic diagnosis in the differential diagnosis between obstructive and nonobstructive forms of neonatal cholestasis, using this clinical situation as a model for a mathematical approach. The study was blind, and we performed it in two steps. In the first step, 49 histologic parameters were visually estimated and were scored on a scale of 0 to 4+ in 100 liver biopsy specimens obtained between 1980 and 1985 from 78 patients with neonatal cholestasis. Forty-eight of these 100 specimens were from patients with final diagnosis of obstructive cholestasis (Group I), and 52 were from patients with nonobstructive cholestasis (Group II). The age range was 3 to 24 weeks (median, 12.5 wk). Twelve histologic variables were selected by chi 2 and Fisher's exact test (P < .05). Next, a series of combinations among these variables were submitted to statistical analysis by logistic regression method, defining a six-variable model that had the most powerful predictive value to classify the type of cholestasis. The variables were portal ductal proliferation, bile plugs in portal bile ductules, portoportal bridges, neutrophils, hepatocyte swelling, and multinucleated giant hepatocytes. The score obtained by this model correspond to the probability of a case belonging to Group I. The accuracy, sensitivity, and specificity rates were 94.0%. In the second step, the model was applied to a new sample of 74 needle-liver biopsy specimens obtained between 1990 and 1995, 45 from patients in Group I and 29 from patients in Group II. The age range was 3 to 15 weeks (median, 8 wk). The accuracy, sensitivity, and specificity rates were 90.5%, 100%, and 75.9%, respectively. In our diagnostic routine, this score has been systematically reported and has been helpful in orienting the therapeutic decision in this group of patients.

Entities:  

Mesh:

Year:  1997        PMID: 9267821

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

1.  Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.

Authors:  Wei-Wei Li; Yan Yang; Qi-Gang Dai; Li-Li Lin; Tong Xie; Li-Li He; Jia-Lei Tao; Jin-Jun Shan; Shou-Chuan Wang
Journal:  Metabolomics       Date:  2018-06-21       Impact factor: 4.290

2.  Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy.

Authors:  Pierre Russo; John C Magee; John Boitnott; Kevin E Bove; Trivellore Raghunathan; Milton Finegold; Joel Haas; Ronald Jaffe; Grace E Kim; Margret Magid; Hector Melin-Aldana; Frances White; Peter F Whitington; Ronald J Sokol
Journal:  Clin Gastroenterol Hepatol       Date:  2011-01-14       Impact factor: 11.382

3.  Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study.

Authors:  Pierre Russo; John C Magee; Robert A Anders; Kevin E Bove; Catherine Chung; Oscar W Cummings; Milton J Finegold; Laura S Finn; Grace E Kim; Mark A Lovell; Margret S Magid; Hector Melin-Aldana; Sarangarajan Ranganathan; Bahig M Shehata; Larry L Wang; Frances V White; Zhen Chen; Catherine Spino
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

4.  AIIMS clinical score: a reliable aid to distinguish neonatal hepatitis from extra hepatic biliary atresia.

Authors:  D K Gupta; M Srinivas; M Bajpai
Journal:  Indian J Pediatr       Date:  2001-07       Impact factor: 1.967

Review 5.  Role of Hepatobiliary Scintigraphy and Preoperative Liver Biopsy for Exclusion of Biliary Atresia in Neonatal Cholestasis Syndrome.

Authors:  Ankur Mandelia; Richa Lal; Nijagal Mutt
Journal:  Indian J Pediatr       Date:  2017-07-08       Impact factor: 1.967

6.  Usefulness of a scoring system in the interpretation of histology in neonatal cholestasis.

Authors:  Way Seah Lee; Lai Meng Looi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

Review 7.  Recent developments in diagnostics and treatment of neonatal cholestasis.

Authors:  Amy G Feldman; Ronald J Sokol
Journal:  Semin Pediatr Surg       Date:  2020-07-23       Impact factor: 2.754

8.  Cytomegalovirus frequency in neonatal intrahepatic cholestasis determined by serology, histology, immunohistochemistry and PCR.

Authors:  Maria Angela Bellomo-Brandao; Paula D Andrade; Sandra C B Costa; Cecilia A F Escanhoela; Jose Vassallo; Gilda Porta; Adriana M A De Tommaso; Gabriel Hessel
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

9.  Morphometric assessment of liver fibrosis may enhance early diagnosis of biliary atresia.

Authors:  Ahmed F Abdalla; Abeer Fathy; Khaled R Zalata; Ahmed Megahed; Ahmed Abo-Alyazeed; Mohammed Ezz El Regal
Journal:  World J Pediatr       Date:  2013-06-17       Impact factor: 2.764

10.  The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease.

Authors:  Grzegorz T Gurda; Qingfeng Zhu; Haibo Bai; Duojia Pan; Kathleen B Schwarz; Robert A Anders
Journal:  Hum Pathol       Date:  2014-01-23       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.